Home > Specialties > Reagents, Immunoassay, Autoimmune, Hepatitis, Liver/Kidney Microsomal Antibody

Reagents, Immunoassay, Autoimmune, Hepatitis, Liver/Kidney Microsomal Antibody

Definition : Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (e.g., serum) to determine antibodies against the cytochrome P450 2D6, specifically against the linear and conformational epitopes of the CYP2D6 protein. These antibodies are generically known as liver/kidney microsomal antibodies type 1 (LKM1); they are frequently found in patients with chronic hepatitis.

Entry Terms : "Microsomal Antibody Determination Reagents, Liver/Kidney" , "LKM1 (Liver/Kidney Microsomal Antibody Type 1) Determination Reagents" , "Liver/Kidney Microsomal Antibody (LKM1) Determination Reagents" , "Kidney/Liver Microsomal Antibody Determination Reagents" , "Cytochrome 450 2D6 Antibody Determination Reagents" , "CYP2D6 Protein Antibody Determination Reagents"

UMDC code : 19320

   

1-13 of 13 Match(es).

DiaSorin AB

DiaSorin AB

DiaSorin Deutschland GmbH

DiaSorin Deutschland GmbH

DiaSorin Iberia SA

DiaSorin Iberia SA

DiaSorin Inc

Diasorin operates in the market for in vitro diagnostics. It produces and distributes reagents to test fluid specimens taken from patients (blood, urine, etc.) in a laboratory setting.

DiaSorin Ltd

DiaSorin Ltd

DiaSorin Ltd (China)

DiaSorin Ltd (China)

DiaSorin Ltd (Israel)

DiaSorin Ltd (Israel)

DiaSorin Ltda

DiaSorin Ltda

DiaSorin Mexico SA de CV

DiaSorin Mexico SA de CV

DiaSorin SA

DiaSorin SA

DiaSorin SA/NV

DiaSorin SA/NV

DiaSorin SpA

DiaSorin SpA

The Binding Site Inc

At Binding Site we constantly strive to improve the tools available to laboratory professionals around the world for diagnosing and monitoring disease. Our origins date back to a group of researchers within the Medical School of Birmingham University who first started looking at innovative ways of producing antibodies in the early 1970's. With a desire to continue this early work but lacking the required government funding they founded a private company to take the research forward and utilise any potential commercial benefits. That company has evolved into The Binding Site and for over 25 years we have specialised in producing highly sensitive and highly specific antibodies used for the detection of certain cancers and other serious disorders.

1-13 of 13 Match(es).

 

Medical Product Guide Optometric Management Product Guide